Home Query References Browse Contact

6 patient data entries in database for clusters G737R and 1.

Entry
#
Mutations
allele 1allele 2
Clinical representationSymptomsAge groupAge of onsetAge of patientAge of deathReference
152A957V1
G737R5
Deceased at 9 months. 30% mtDNA copy number in muscle, 30% mtDNA copy number in blood, 10% mtDNA copy number in liver.
-no known symptoms
infantile
n/a0.40.8Tang et al, 2011;

[view data]

153V855L1
G737R5
Hypoglycaemia, liver failure, seizures, developmental delay. 65% mtDNA copy number in muscle, ETC low.
-liver failure
-developmental delay
infantile
n/a0.8n/aTang et al, 2011;

[view data]

74G737R5
G426S1
Seizures, intractable seizures, abnormal EEG, abnormal MRI. 135% mtDNA copy number in blood.
-intractable seizure
childhood
n/a11n/aTang et al, 2011;

[view data]

154R943C1
E1143G
G737R5
Onset at age 3 with dementia,lactic acidosis, renal tubulopathy, dysmorphic features, cataract, short stature, myopathy.
-lactic acidosis
-myopathy
-dementia
-renal tubulopathy
childhood
3n/an/aWong et al, 2008;

[view data]

190G737R5
R853W1
Migraines in childhood, In 20s presented with peripheral sensory neuropathy and parkinsonisms.
-sensomotor neuropathy
-parkinson's disease
-headache/ migraine
childhood
n/an/an/aDavidzon et al, 2006;

[view data]

669R853W1
G737R5
parkinsonism with dystonic toe and plantar flexion. Anxiety and generalized muscle weakness. Bilateral hypaesthesia of the lateral bottom of the foot and dorsal forefoot as well as bilateral distal pallhypaesthesia of the legs. Slight bilateral ptosis, slight axonal sensory polyneuropathy.
-polyneuropathy
-muscle weakness
-ptosis
-parkinson's disease
adult
2732n/aRempe et al, 2016;

[view data]

1-5 pathogenic cluster assignment of mutations. Mutations displayed without a superscript number are outside of the assigned pathogenic clusters. See cluster definitions for details.

Number of displayed patient cases: 6
Avg age of onset in displayed cases: 8.4
Std dev in onset in displayed cases: 10.0

Search criteria for patient entries:
Mutations Entry IDs Clusters Reference Residue range
Patients for cluster combinations:
First cluster: Second cluster:
Age group: Any Infantile Childhood Juvenile Adult
:.: Privacy Statement :.: Disclaimer :.: Contact Information :.: